THE FALSE-POSITIVE TUMOR-MARKER IN MALIGNANT-TUMOR OF THE TESTIS

被引:0
|
作者
BUSSARMAATZ, R
WEISSBACH, L
DAHLMANN, N
MANN, K
机构
[1] KRANKENHAUS HARBURG,ZENTRALLABOR,HAMBURG,GERMANY
[2] KLINIKUM GROSSHARDEN,MED KLIN 2,MUNICH,GERMANY
来源
UROLOGE-AUSGABE A | 1993年 / 32卷 / 03期
关键词
TESTICULAR TUMOR; ALPHA-FETOPROTEIN; CHORION GONADOTROPIN; HETEROPHILIC ANTIBODIES; FOLLOW-UP;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In addition to the histological diagnosis, alpha fetoprotein (AFP) and chorion gonadotropin (HCG) are used in clinical staging, therapy monitoring, and follow-up. Elevated markers without localization of metastases by imaging procedures are generally classified as progressive disease. However, other causes may be responsible for the elevated tumor markers: other malignant or benign diseases such as hepatocellular carcinomas, gastrointestinal tumors, bronchial carcinomas and benign diseases of the liver for AFP, and vesicular mole, hepatocellular, stomach, pancreatic and urothelial carcinomas for HCG. Moreover, technical disturbances in the modern sandwich assays with monoclonal antibodies are possible by heterophilic antibodies. These human anti-animal antibodies are built after immunoscintigraphy, immunostimulation and oral immunization by macromolecules. As a result, if progressive disease of a malignant germ cell tumor is unlikely, several steps have to be taken to determine the true causes for the elevated tumor markers before chemotherapy can be applied.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 50 条
  • [1] TUMOR-MARKER LEVELS AND PROGNOSIS IN MALIGNANT TERATOMA OF THE TESTIS
    BEGENT, RHJ
    GERMALLUCH, JR
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 197 - 197
  • [2] TUMOR-MARKER LEVELS AND PROGNOSIS IN MALIGNANT TERATOMA OF THE TESTIS
    GERMALLUCH, JR
    BEGENT, RHJ
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1980, 42 (06) : 850 - 855
  • [3] CLINICAL USEFULNESS AND FALSE-POSITIVE RESULTS OF CA 125 AS A TUMOR-MARKER OF OVARIAN-CANCER - A STUDY ON 674 PATIENTS
    TAKAHASHI, K
    SHIBUKAWA, T
    MORIYAMA, M
    SHIRAI, T
    KIJIMA, S
    IWANARI, O
    MATSUNAGA, I
    KITAO, M
    JAPANESE JOURNAL OF SURGERY, 1986, 16 (05): : 305 - 310
  • [4] FALSE-POSITIVE BRAIN-TUMOR
    WEINTRAUB, MI
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (05) : 775 - 775
  • [5] REGIONAL PERICARD MESOTHELIOMA WITH POSITIVE TUMOR-MARKER
    KLEINEKATTHOFER, P
    BEHRENBECK, T
    ENGBERDING, RE
    PIERCHALLA, P
    TUMORDIAGNOSTIK & THERAPIE, 1988, 9 (04) : 159 - 162
  • [6] FALSE-POSITIVE TUMOR FINDINGS OF RIGHT SEMICOLON
    ANDERS, A
    PEVERETOS, P
    TAENZER, V
    CHIRURG, 1974, 45 (03): : 127 - 130
  • [7] TRANSIENT TUMOR-MARKER SURGE FOLLOWING CHEMOTHERAPY OF TESTIS TUMORS
    SHETTY, MR
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 785 - 785
  • [8] TRAUMA AND THE MALIGNANT-TUMOR
    GLASER, A
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1990, 45 (12): : 1092 - 1095
  • [9] ANGIOTENSIN CONVERTING ENZYME - A TUMOR-MARKER IN MALIGNANT HISTIOCYTOSIS
    BOOMSMA, F
    MICHIELS, JJ
    PRINS, E
    ABELS, J
    SCHALEKAMP, MADH
    BRITISH MEDICAL JOURNAL, 1983, 286 (6371): : 1106 - 1106
  • [10] INACTIVE RENIN - A TUMOR-MARKER FOR MALIGNANT RENAL TUMORS
    LINDOP, GBM
    MILLAN, DW
    GIBSON, AAM
    CARACHI, R
    LECKIE, BJ
    JOURNAL OF PATHOLOGY, 1987, 151 (01): : A63 - A63